Charlene M Fares

University of California Los Angeles - Los Angeles / United States

Medical and Health Sciences / Medical Oncology

AD Scientific Index ID: 4585600

University of California

Registration, Add Profile,
Premium Membership

Print Your Certificate

Charlene M Fares's MOST POPULAR ARTICLES

1-) Mechanisms of resistance to immune checkpoint blockade: why does checkpoint inhibitor immunotherapy not work for all patients?CM Fares, EM Van Allen, CG Drake, JP Allison, S Hu-LieskovanAmerican Society of Clinical Oncology Educational Book 39, 147-164, 20193882019

2-) Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44AL Cummings, J Gukasyan, HY Lu, T Grogan, G Sunga, CM Fares, ...Nature cancer 1 (12), 1167-1175, 2020192020

3-) Low concordance of patient-reported outcomes with clinical and clinical trial documentationCM Fares, TJ Williamson, MK Theisen, A Cummings, K Bornazyan, ...JCO clinical cancer informatics 2, 1-12, 2018192018

4-) Association of PD-L1 expression by immunohistochemistry and gene microarray with molecular subtypes of ovarian tumorsCD Chin, CM Fares, M Campos, HW Chen, IP Shintaku, GE Konecny, ...Modern Pathology 33 (10), 2001-2010, 2020162020

5-) Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLCN Zhou, MA Velez, B Bachrach, J Gukasyan, CM Fares, AL Cummings, ...Lung Cancer 161, 34-41, 2021102021

ARTICLES

Add your articles